|Bid||194.42 x 800|
|Ask||194.51 x 1400|
|Day's Range||191.40 - 196.89|
|52 Week Range||124.54 - 226.30|
|Beta (5Y Monthly)||0.85|
|PE Ratio (TTM)||34.29|
|Earnings Date||Jul 23, 2020 - Jul 27, 2020|
|Forward Dividend & Yield||2.30 (1.18%)|
|Ex-Dividend Date||Jun 29, 2020|
|1y Target Est||205.18|
In this article you are going to find out whether hedge funds think Stryker Corporation (NYSE:SYK) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]
Moody's Investors Service ("Moody's") today assigned a Baa1 rating to Stryker Corporation's ("Stryker") proposed offering of senior unsecured notes. Proceeds from the offering will be used to fund Stryker's pending $5.4 billion (including repayment of outstanding convertible debt) acquisition of Wright Medical Group B.V. ("Wright Medical").
Stryker (SYK) (the “Company”) announced today that it has priced the following senior notes: (i) $650 million aggregate principal amount of the Company’s 1.150% Notes due 2025 (the “2025 Notes”), (ii) $1 billion aggregate principal amount of the Company’s 1.950% Notes due 2030 (the “2030 Notes”), and (iii) $650 million aggregate principal amount of the Company’s 2.900% Notes due 2050 (the “2050 Notes” and, collectively with the 2025 Notes and the 2030 Notes, the “Notes”). The offering of the Notes is expected to settle on June 4, 2020, subject to the satisfaction of customary closing conditions.
RTI Surgical Holdings, Inc. (RTIX), a global surgical implant company, today announced the appointment of Stuart F. Simpson as an independent member of its board of directors. Mr. Simpson most recently served as the President of the Joint Replacement Division of Stryker Corporation (SYK), a medical technology company that provides products and services in orthopedics, medical and surgical, and neurotechnology and spine (“Stryker”), from 2017 until his departure from Stryker in 2019. Mr. Simpson held various roles at Stryker from 1997 until 2019, including VP & General Manager of the Commercial Business Unit from 2015 until 2017 and VP & General Manager of the Global Knee & Mako Business Unit from 2014 until 2015.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Stryker Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
George Young, Portfolio Manager at the Villiere Balanced Fund, joined Yahoo Finance's Jen Rogers, Myles Udland, Dan Roberts, and Melody Hahm to discuss the stocks he's watching and his outlook for the market.
Today we'll look at Stryker Corporation (NYSE:SYK) and reflect on its potential as an investment. In particular, we'll...
KELOWNA, BC , May 13, 2020 /CNW/ - Panorama Capital Corp. (PANO-P.V) (the "Company" or "Panorama"), a capital pool company ("CPC"), is pleased to announce it has entered into a non-binding letter of intent dated May 12, 2020 (the "LOI") to enter into an arm's length business combination transaction (the "Proposed Transaction") with Avisa Pharma Inc. ("Avisa"). Established in 2010, Avisa is a private medical device company with its head office in Santa Fe, New Mexico and incorporated under the laws of the State of Delaware . Avisa has developed a quantitative, point-of-care diagnostic breath test known as the Avisa BreathTest ("ABT") for rapidly detecting bacterial pneumonia and pulmonary infections in approximately 10 minutes.
The Food and Drug Administration’s decision to crack down on a loose set of regulatory requirements for antibody tests follows concerns about test validity and fraud.
Kalamazoo, Michigan, May 05, 2020 -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on July 31, 2020 to.
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
Stryker (SYK) delivered earnings and revenue surprises of 8.88% and 5.37%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Kalamazoo, Michigan, April 30, 2020 -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2020: The response to the COVID-19 pandemic has included.
With hospitals devoting nearly all their efforts to deal with the pandemic, elective procedures are being put on the backburner Continue reading...
Stryker (SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (WMGI). The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical.
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Today we're going to take a look at the well-established Stryker Corporation (NYSE:SYK). The company's stock saw a...
Some investors are wary about buying into a recent stock market rally. "The market seems to be pricing in a light switch reopening in May or June, and it's more likely to be a slow, staggered reopening that will cause more economic damage the longer the shutdown lasts," said David Lafferty, chief market strategist at Natixis Investment Managers.
Kalamazoo, Michigan, April 09, 2020 -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 30, 2020 at 4:30 p.m., Eastern Time, to discuss the.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.
Healthcare has held up better than most S&P 500 sectors. Since the S&P 500 hit an all-time high on Feb. 19, healthcare is down about 18% as of Wednesday, while the benchmark index has tumbled 27%. The sector is typically considered a defensive area of the market because some investors believe consumers will continue buying healthcare products even during uncertain times.